Anupam Rasayan India to Acquire Up to 742 Stake in Bliss GVS Pharma in Rs 1360 Crore Deal Broadcom Meta and Tech Giants Invest 125 Million in UCLA Semiconductor Research Hub Vertiv VRT Expands Power Protection Portfolio with Launch of PowerUPS 100 Standby Series in North America Alibaba Unveils NextGeneration Zhenwu AI Chip and New Large Language Model US Real GDP Growth Trends 19802031 Historical Performance and Forward Projections ConocoPhillips Receives 4 Price Target Boost from Morgan Stanley SEED Q4 2011 Earnings EPS Surges 117 Above Estimates Strong Operational Execution IMMR Q3 2025 Earnings EPS Surges Past Estimates as Haptic Licensing Gains Momentum Badger Meter BMI Q1 2026 Earnings EPS Misses Estimates by 248 as Stock Rises 108 PANW Q1 2026 Earnings Strong EPS Beat Amid Robust Cybersecurity Demand EVgo Q1 2026 Earnings Narrower Loss Beats Expectations Amid Steady Operational Progress GPRO Q1 2026 Earnings Massive EPS Miss Despite Stock Rally TPG Mortgage Investment Trust Inc MITT Gains Ground Above Key Support Gladstone Investment Notes GAING Hold Steady at 2532 as Market Awaits Rate Clarity Pool Corporation POOL Faces Selling Pressure as Shares Dip Below Key Levels RiverNorth Opportunistic Municipal Income Fund RMI Posts Modest Gain as Price Holds Near Key Resistance Sabra Health Care REIT SBRA Slips 106 Support and Sector Headwinds in Focus Vicor Corporation VICR Q1 2026 Earnings EPS Surges Past Estimates by Nearly 20 Xenetic Biosciences Q2 2025 Earnings Narrowed Loss Exceeds Expectations Amid Oncology Pipeline Progress CPS Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Rises NXTC Q1 2026 Earnings SmallerthanExpected Loss but Stock Plunges 22 as Revenue Stays at Zero ANF Q1 2026 Earnings EPS Beat by 20 as Cost Discipline Drives Profitability PRA Group Inc PRAA Q1 2026 Earnings EPS Surprises to the Upside Amid Limited Revenue Detail Wall Street Analysts Weigh In on Align Technology What the Target Prices Suggest LATAM Airlines Q1 2026 Earnings Narrow Profit Beat Fails to Lift Shares as Operational Headwinds Persist Polaryx Therapeutics PLYX Slides 86 as Stock Tests Key Support Levels